Toggle light / dark theme

Human longevity at the cost of reproductive success: evidence from global data

Ageing, defined as the decline in survival probability and fecundity with advancing adult age, is often viewed as the evolutionary outcome of the declining force of natural selection at older age (17 ; 22). Ageing can be due to the accumulation of late acting deleterious mutations (17 ; 12 ; 4), and/or due to pleiotropy, as the result of constrained life-history optimization (36 ; 4 ; 22 ; 38). For instance, increased allocation of limited resources to reproduction can be an important cause of senescence and later mortality (17 ; 35 ; 14 ; 15 ; 31). Most of the evidence for this phenomenon comes from experiments showing the deleterious consequences of an increase in reproductive effort on life span (21 ; 32 ; 3 ; 10 ; 24 ; 28). Artificial selection on age at reproduction showed the reverse effect that selection regime favouring individuals that retained fecundity at a later age resulted in populations with increased life spans (7 ; 39 ; 22). Data for higher organisms, e.g. mammals, have until now been mostly lacking.

The hypothesis that investment in reproduction reduces the resources available for somatic maintenance has recently been tested in Homo sapiens by 33 ). Using 1,200 years of genealogical data on British aristocracy, they showed that the number of progeny was small for women who died at an early age, increased with the age of death, reached a plateau through the sixth, seventh and eighth decades of life, and was lower again for women who died at an age of 80 years or over. This relationship supported the expectation that heavy investments in reproduction diverts resources away from the maintenance and repair of cells, with ageing and earlier death as results (33). For unknown reasons, the authors found a virtually identical pattern among men.

As manipulative experiments on humans are unethical, the statistical search for congruent patterns offers an alternative to understand variation in life-history parameters among human populations. Fortunately, there are considerable statistics on humans and their activities, and other ways of detecting similar patterns and of testing relevant hypotheses are possible. The aim of the present paper is to assess the generality of this trade-off among humans. We test whether the variation of life-history parameters found in the study of British aristocrats is also present across different human populations worldwide. After controlling longevity and fecundity for possible effects exerted by historical, spatial, economical and population patterns, we determined the relationship between longevity and fecundity, using data from 153 countries located all over the world.

New study identifies how memory of personal interactions declines with age

One of the most upsetting aspects of age-related memory decline is not being able to remember the face that accompanies the name of a person you just talked with hours earlier. While researchers don’t understand why this dysfunction occurs, a new study conducted at University of Maryland School of Medicine (UMSOM) has provided some important new clues. The study was published on September 8 in Aging Cell.

Using aging , researchers have identified a new mechanism in neurons that causes memories associated with these social interactions to decline with age. In addition, they were able to reverse this in the lab.

The researchers report that their findings identified a specific target in the brain that may one day be used to develop therapies that could prevent or reverse loss due to typical aging. Aging memory problems are distinct from those caused by diseases like Alzheimer’s or dementia. At this time, there are no medications that can prevent or reverse cognitive decline due to typical aging.

Elon Musk’s NEURALINK vs Bryan Johnson’s KERNEL (No Surgery)

00:00 Intro.
02:44 Kernel Flow brain interface.
08:03 Seeing my brain activity.
12:42 Reversing aging-Project Blueprint.
18:18 Overcoming depression.
26:42 Starting Kernel.
34:40 Why non-invasive?
36:43 Comparison to Tesla/ Neuralink.
43:52 Elon considered joining Kernel?
44:52 Kernel hiring.
46:17 Participate in the studies.

Participate & experience Kernel Flow: https://www.kernel.com/participate.
Information: Kernel Flow: https://www.kernel.com/flow.
Kernel Careers: https://jobs.lever.co/kernel-2
Neura Pod Episode about Kernel & Bryan Johnson: https://youtu.be/c0VFiEhDg6I
Bryan Johnson LinkedIn: https://www.linkedin.com/in/bryanrjohnson/
Bryan Johnson Personal Page: https://www.bryanjohnson.co/
Blueprint Website: https://blueprint.bryanjohnson.co/

After selling his company, Braintree/Venmo, for $800 million and battling chronic depression for 10 years, Bryan Johnson is now on a mission to help us measure and gather more data about the organ that makes us oh-so human: our brain.

In this episode, Ryan Tanaka and Omar Olivares share an exclusive, behind the scenes look of Kernel’s headquarters near Los Angeles, California. Ryan interviews Bryan Johnson, tries on Kernel’s wearable brain-interface, ‘Flow,’ and learns about the engineering and technology developments needed to make it all happen. CTO, Ryan Field and Director of Applied Neuroscience, Katherine Perdue also share insights about Kernel’s wearable Flow headset.

Disclaimer: Thanks to Kernel for opening their office for us to film in and for supporting our travel and accommodation.

Neura Pod is a series covering topics related to Neuralink, Inc. Topics such as brain-machine interfaces, brain injuries, and artificial intelligence will be explored. Host Ryan Tanaka synthesizes informationopinions, and conducts interviews to easily learn about Neuralink and its future.

The Biggest Technologies of Antiaging, Space and Robotics will change the World by 2035

A talk for the international audience of Technology Universe (https://technologyuniverse.net/) by futurist Brian Wang.

Other videos by Brian Wang on Space, Replicating factories, future teslabots and antiaging.

Fully and Rapidly Replicable Factories — the Most Important Product Ever.

Brian Wang interviews Aubrey de Grey.

Megapixel Images of the surface of other worlds.

SpaceX will get to hourly rocket launches within 4 Years.

How a single protein could unlock age-related vision loss

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

The study, published recently in the Biophysical Journal, describes the flexible structure of a key blood protein involved in macular degeneration and other age-related diseases, such as Alzheimer’s and atherosclerosis.

“Proteins in the blood are under constant and changing pressure because of the different ways blood flows throughout the body,” says Marassi. “For example, blood flows more slowly through small blood vessels in the eyes compared to larger arteries around the heart. Blood proteins need to be able to respond to these changes, and this study gives us fundamental truths about how they adapt to their environment, which is critical to targeting those proteins for future treatments.”

The Welwitschia genome reveals a unique biology underpinning extreme longevity in deserts

Circa 2021 face_with_colon_three


Welwitschia mirabilis is a unique plant that only has two leaves, but it can survive in hostile conditions of the African desert. Here, the authors report its chromosome-level genome assembly and discuss how gene function and regulation have given rise to its unique morphology and environmental adaptions.

Cyborgs, Futurists, & Transhumanism: A Conversation

Cyborgs transhumanist and futurists.


Museum of Science | Boston, MA
March 28th, 2018

We’ve all heard of Terminator, Blade Runner, and other science fiction about cyborgs. But how far is reality from fiction? Can scientists transform humans into machine-like creatures, stronger, smarter and, who knows, even immortal?

Join us for a unique conversation about our transhumanist future with neuroscientist Ed Boyden, leader of the Synthetic Neurobiology Group and associate professor of Biological Engineering and Brain and Cognitive Sciences at the MIT Media Lab and McGovern Institute for Brain Research; humanist Mark O’Connell, journalist and author of To Be a Machine: Adventures Among Cyborgs, Utopians, Hackers, and the Futurists Solving the Modest Problem of Death; and physicist Marcelo Gleiser, director of the Institute for Cross-Disciplinary Engagement at Dartmouth College.

Umbilical Plasma Injections Reduce Biological Age in Humans

A year back and bodily function improves, and it’s a shot rather than transfusion as needed from other plasma treatments.


Researchers have found that intramuscular injections of plasma concentrate made from human umbilical cord blood improve various health biomarkers and decrease biological age in elderly people [1].

Circulating proteins have a significant impact on our health, and blood plasma transfusion is increasingly used against inflammatory conditions as well as some autoimmune and genetic diseases [2]. Basically, plasma transfusion enables physicians to alter the concentration of interesting molecules in the blood.

In recent years, Michael and Irina Conboy, along with other researchers, have experimented with blood/plasma exchange in the context of longevity [3]. Their continuing research has shown that heterochronic parabiosis (blood exchange between old and young animals), as well as plasma transfusion and even dilution of old plasma [4], alleviate various aspects of aging and decrease biological age as measured by methylation clocks.